Diamond Shruumz mushroom products recalled after causing illness

Category: Health

The Vermont Department of Health warns against using Diamond Shruumz edible hallucinogenic products due to investigations into two deaths and over 70 illnesses linked to the brand. Despite a nationwide recall, some products may still be available for purchase.

Keywords: Vermont Department of Health, Diamond Shruumz, edible hallucinogens

Source: WCAX

Update At: 7/25/2024

Related Sources

UVA professor discusses neurological condition affecting Celine Dion

Celine Dion has been diagnosed with Stiff Person Syndrome, leading to a loss of muscle control.

WLBT

Lawmaker Uses AI Voice to Speak on House Floor

Rep. Jennifer Wexton, affected by progressive supranuclear palsy, uses AI to regain her voice, delivering a speech in the US House. This emotional moment highlights her determination to help others despite her health challenges.

Newser

Gymnastics-Olympic champion Onodi's family seeking funds for rehab

Henrietta Onodi, a former Hungarian gymnast and Olympic gold medalist, is seeking financial support for rehabilitation after suffering a massive heart attack. Her family has launched a crowdfunding campaign to assist with her long-term care following her sudden collapse in March.

The Straits Times

Olympics-Gymnastics-Olympic champion Onodi's family seeking funds for rehab

Henrietta Onodi, a former Hungarian gymnast and Olympic gold medalist, is seeking financial support for rehabilitation after suffering a massive heart attack. Her family has launched a GoFundMe campaign to assist with her long-term care following her sudden collapse in a grocery store.

Yahoo News UK

"Stop using" unsafe kitchen spice, FDA warns

Health officials have warned consumers to stop using El Servidor ground cinnamon due to elevated lead levels, which may pose health risks, especially for babies and young children. The FDA has stated that there is no safe level of lead exposure and is investigating the issue while recommending a voluntary recall of the product.

Newsweek

Alzheimer’s blood test catches 90% of early dementia cases, study finds

A new blood test for cognitive decline shows a 90% accuracy rate in diagnosing Alzheimer's disease, significantly outperforming traditional diagnostic methods. The test measures plasma phosphorylated tau 217 (p-tau217) and combines it with the amyloid 42/40 ratio to enhance diagnostic precision. Experts believe that once validated, these blood tests could revolutionize Alzheimer's diagnosis and treatment, potentially reducing wait times for patients seeking new therapies.

CNN

How a new technology might accelerate Alzheimer's testing, treatment for millions

New blood tests for Alzheimer's disease may replace traditional diagnostic methods, allowing for earlier detection and treatment. Research shows these tests can accurately identify the disease, potentially improving access to medications and reducing wait times for diagnosis. The Precivity AD2 test has shown promising results, detecting 90% of cases compared to lower rates by specialists. As the demand for quicker diagnoses grows, these blood tests could transform Alzheimer's care.

USA Today

Alzheimer’s blood test shows 90% accuracy, outperforming other exams

A new study reveals that a blood test can diagnose Alzheimer's disease with 90% accuracy, outperforming traditional methods used by specialists and primary care doctors. This test could provide a cheaper and less invasive alternative to current diagnostic procedures, potentially improving patient outcomes and preparation for care needs.

The Washington Post

A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

A new blood test for Alzheimer's disease shows 90% accuracy in diagnosing patients with memory problems, outperforming traditional cognitive tests and CT scans. This advancement could lead to more accessible and affordable diagnostic methods for Alzheimer's, which affects millions globally. The study emphasizes the importance of using blood tests as part of a comprehensive screening process, particularly for individuals showing symptoms of cognitive decline.

The New York Times

Groundbreaking blood test could hold key to diagnosing Alzheimer’s

New blood tests show promise in diagnosing Alzheimer's disease more accurately and quickly than traditional methods. A recent study indicates that these tests can achieve up to 91% accuracy, significantly higher than the 61% and 73% accuracy rates of primary care doctors and specialists, respectively. However, the tests are not yet widely used due to a lack of FDA approval and insurance coverage. Experts recommend using blood tests only for patients with memory issues and caution against their use for asymptomatic individuals.

New York Post